We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Opioid and Non-Opioid Pharmacotherapy Use for Pain Management Among Privately Insured Pediatric Patients With Cancer in the United States.
- Authors
Shen, Chan; Thornton, J Douglas; Li, Ning; Schaefer, Eric; Zhou, Shouhao; Kawasaki, Sarah; Pameijer, Colette; Leslie, Douglas
- Abstract
Background This study examined the trends and patterns of opioid and non-opioid pharmacotherapy use among a large national sample of privately insured pediatric patients with cancer in the United States. Materials and Methods We identified pediatric (aged < 21) patients diagnosed with central nervous system (CNS), lymphoma, gonadal, leukemia, or bone cancer from MarketScan data 2005-2019. We examined the proportion of patients who filled a prescription for the following 5 types of pharmacotherapy: opioid, anticonvulsant, non-steroidal anti-inflammatory drug (NSAID), antidepressant, and muscle relaxant during active cancer treatment. We assessed the trends and patterns in pharmacotherapy using multivariable logistic regressions. Results Among 4174 patients included, 2979 (71%) had an opioid prescription; 746 (18%), 384 (9%), 202 (5%), and 169 (4%) had anticonvulsant, NSAID, antidepressant and muscle relaxant prescriptions, respectively. Multivariable logistic regression showed a nonlinear trend in the use of opioids among pediatric patients with cancer over time such that use slightly increased until 2012 (OR of 1.40 [95% CI, 1.12-1.73] for 2012 vs. 2006) but then decreased thereafter (OR of 0.51 [0.37-0.68] for 2018 vs. 2012). The use of anticonvulsants, NSAIDs, and muscle relaxants increased significantly linearly over time (all P < .005). Conclusion There has been a downward trend in the use of opioids in recent years among pediatric patients with cancer and an upward trend in the use of non-opioid pharmacotherapy for pain management potentially as an alternative to opioids.
- Subjects
UNITED States; LYMPHOMA diagnosis; LEUKEMIA diagnosis; ANTICONVULSANTS; ANTIDEPRESSANTS; MUSCLE relaxants; CONFIDENCE intervals; NONOPIOID analgesics; NONSTEROIDAL anti-inflammatory agents; MULTIVARIATE analysis; PEDIATRICS; CANCER patients; BONE tumors; DRUGS; HEALTH insurance; RESEARCH funding; DRUG utilization; OPIOID analgesics; MEDICAL prescriptions; LOGISTIC regression analysis; ODDS ratio; CENTRAL nervous system; PAIN management; CHILDREN
- Publication
Oncologist, 2024, Vol 29, Issue 2, p176
- ISSN
1083-7159
- Publication type
Article
- DOI
10.1093/oncolo/oyad292